Our current data show that SLC20A2 mediates the reduction of calcification by cells treated with vitamin D. Mutations for SLC20A25, 9, 14, 21 and, more recently, XPR111 have been found in PFBC patients, typified by brain calcification. The gene discussed is SLC20A2; the disease is bilateral striopallidodentate calcinosis.